Outcomes among Thai children with risk conditions hospitalized for pneumococcal disease (invasive or non-bacteraemic pneumonia) : A multi-centre, observational study
© 2023 Pfizer Inc..
Objective: To describe the risk condition status and clinical outcomes among Thai children hospitalized with pneumococcal disease.
Methods: In this retrospective analysis, children with invasive pneumococcal disease (IPD) or x-ray-confirmed non-bacteraemic pneumococcal pneumonia (NBPP) were identified from nine hospitals in Thailand between 2010 and 2019. Data on risk factors and outcomes were extracted from medical records.
Results: In total, 413 cases were identified: 319 IPD and 94 NBPP. Overall, 133 (32.2%) patients were admitted to intensive care units and 11/406 (2.7%) died. Twenty-seven percent of IPD cases had at-risk conditions and 15% had high-risk conditions. Most IPD cases (32.9%) occurred in children aged 2-4 years, and most NBPP cases (28.7%) occurred in infants aged 0-11 months. Of 51 Streptococcus pneumoniae isolates collected, 41 (80%) were pneumococcal 13-valent conjugate vaccine serotypes. Only 5.1% of children had received a pneumococcal vaccine.
Conclusions: Most children with IPD and NBPP did not have high-risk or at-risk conditions, while 42% had at-risk or high-risk conditions for pneumococcal disease. Very few children in the cohort had received any type of pneumococcal vaccine. Increasing the availability of pneumococcal conjugate vaccines should be considered to reduce the burden of pneumococcal disease among children in Thailand.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:8 |
|---|---|
| Enthalten in: |
IJID regions - 8(2023) vom: 01. Sept., Seite 49-57 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Phongsamart, Wanatpreeya [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Invasive pneumococcal disease (IPD) |
|---|
| Anmerkungen: |
Date Revised 18.07.2023 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1016/j.ijregi.2023.06.001 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM359170625 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM359170625 | ||
| 003 | DE-627 | ||
| 005 | 20231226080316.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.ijregi.2023.06.001 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1197.xml |
| 035 | |a (DE-627)NLM359170625 | ||
| 035 | |a (NLM)37415954 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Phongsamart, Wanatpreeya |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Outcomes among Thai children with risk conditions hospitalized for pneumococcal disease (invasive or non-bacteraemic pneumonia) |b A multi-centre, observational study |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 18.07.2023 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a © 2023 Pfizer Inc. | ||
| 520 | |a Objective: To describe the risk condition status and clinical outcomes among Thai children hospitalized with pneumococcal disease | ||
| 520 | |a Methods: In this retrospective analysis, children with invasive pneumococcal disease (IPD) or x-ray-confirmed non-bacteraemic pneumococcal pneumonia (NBPP) were identified from nine hospitals in Thailand between 2010 and 2019. Data on risk factors and outcomes were extracted from medical records | ||
| 520 | |a Results: In total, 413 cases were identified: 319 IPD and 94 NBPP. Overall, 133 (32.2%) patients were admitted to intensive care units and 11/406 (2.7%) died. Twenty-seven percent of IPD cases had at-risk conditions and 15% had high-risk conditions. Most IPD cases (32.9%) occurred in children aged 2-4 years, and most NBPP cases (28.7%) occurred in infants aged 0-11 months. Of 51 Streptococcus pneumoniae isolates collected, 41 (80%) were pneumococcal 13-valent conjugate vaccine serotypes. Only 5.1% of children had received a pneumococcal vaccine | ||
| 520 | |a Conclusions: Most children with IPD and NBPP did not have high-risk or at-risk conditions, while 42% had at-risk or high-risk conditions for pneumococcal disease. Very few children in the cohort had received any type of pneumococcal vaccine. Increasing the availability of pneumococcal conjugate vaccines should be considered to reduce the burden of pneumococcal disease among children in Thailand | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Invasive pneumococcal disease (IPD) | |
| 650 | 4 | |a Non-bacteraemic pneumococcal pneumonia | |
| 650 | 4 | |a PCV13 | |
| 650 | 4 | |a Pneumococcal conjugate vaccine | |
| 650 | 4 | |a Pneumococcal pneumonia | |
| 700 | 1 | |a Allen, Kristen E |e verfasserin |4 aut | |
| 700 | 1 | |a Vandepitte, Warunee Punpanich |e verfasserin |4 aut | |
| 700 | 1 | |a Techasaensiri, Chonnamet |e verfasserin |4 aut | |
| 700 | 1 | |a Kosalaraksa, Pope |e verfasserin |4 aut | |
| 700 | 1 | |a Laoprasopwattana, Kamolwish |e verfasserin |4 aut | |
| 700 | 1 | |a Khantee, Puttichart |e verfasserin |4 aut | |
| 700 | 1 | |a Udompornwattana, Songkiat |e verfasserin |4 aut | |
| 700 | 1 | |a Suwanpakdee, Detchvijitr |e verfasserin |4 aut | |
| 700 | 1 | |a Sudjaritruk, Tavitiya |e verfasserin |4 aut | |
| 700 | 1 | |a Puthanakit, Thanyawee |e verfasserin |4 aut | |
| 700 | 1 | |a Anugulruengkitt, Suvaporn |e verfasserin |4 aut | |
| 700 | 1 | |a Southern, Jo |e verfasserin |4 aut | |
| 700 | 1 | |a Fletcher, Mark A |e verfasserin |4 aut | |
| 700 | 1 | |a Dunne, Eileen M |e verfasserin |4 aut | |
| 700 | 1 | |a Thamaree, Ruangwit |e verfasserin |4 aut | |
| 700 | 1 | |a Morales, Graciela |e verfasserin |4 aut | |
| 700 | 1 | |a Chokephaibulkit, Kulkanya |e verfasserin |4 aut | |
| 700 | 1 | |a Chotpitayasunondh, Tawee |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t IJID regions |d 2021 |g 8(2023) vom: 01. Sept., Seite 49-57 |w (DE-627)NLM342413988 |x 2772-7076 |7 nnns |
| 773 | 1 | 8 | |g volume:8 |g year:2023 |g day:01 |g month:09 |g pages:49-57 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.ijregi.2023.06.001 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 8 |j 2023 |b 01 |c 09 |h 49-57 | ||